BRPI0407368A - tratamento de doenças bacterianas dos órgãos respiratórios mediante aplicação local e fluor-quinolonas. - Google Patents

tratamento de doenças bacterianas dos órgãos respiratórios mediante aplicação local e fluor-quinolonas.

Info

Publication number
BRPI0407368A
BRPI0407368A BRPI0407368-1A BRPI0407368A BRPI0407368A BR PI0407368 A BRPI0407368 A BR PI0407368A BR PI0407368 A BRPI0407368 A BR PI0407368A BR PI0407368 A BRPI0407368 A BR PI0407368A
Authority
BR
Brazil
Prior art keywords
treatment
fluorquinolones
local application
bacterial diseases
respiratory organs
Prior art date
Application number
BRPI0407368-1A
Other languages
English (en)
Inventor
Rainer Endermann
Harald Labischinski
Christoph Ladel
Uwe Petersen
Ben Newton
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32851853&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0407368(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10305319A external-priority patent/DE10305319A1/de
Priority claimed from DE10305318A external-priority patent/DE10305318A1/de
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of BRPI0407368A publication Critical patent/BRPI0407368A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"TRATAMENTO DE DOENçAS BACTERIANAS DOS óRGãOS RESPIRATóRIOS MEDIANTE APLICAçãO LOCAL DE FLUOR-QUINOLONAS". A presente invenção refere-se a composições de derivado do ácido quinolónico inaláveis para o combate local de doenças dos órgãos respiratórios, especialmente de doenças pulmonares.
BRPI0407368-1A 2003-02-10 2004-01-28 tratamento de doenças bacterianas dos órgãos respiratórios mediante aplicação local e fluor-quinolonas. BRPI0407368A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10305319A DE10305319A1 (de) 2003-02-10 2003-02-10 Behandlung bakteriell verursachter Lungenkrankheiten
DE10305318A DE10305318A1 (de) 2003-02-10 2003-02-10 Behandlung bakteriell verursachter Lungenkrankheiten
PCT/EP2004/000710 WO2004069253A1 (de) 2003-02-10 2004-01-28 Behandlung bakterieller erkrankungen der atmungsorgane durch lokale applikation von fluorchinolonen

Publications (1)

Publication Number Publication Date
BRPI0407368A true BRPI0407368A (pt) 2006-02-14

Family

ID=32851853

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0407368-1A BRPI0407368A (pt) 2003-02-10 2004-01-28 tratamento de doenças bacterianas dos órgãos respiratórios mediante aplicação local e fluor-quinolonas.

Country Status (28)

Country Link
US (2) US8034817B2 (pt)
EP (1) EP1594500B1 (pt)
JP (2) JP4828405B2 (pt)
KR (1) KR101173696B1 (pt)
AR (1) AR043117A1 (pt)
AT (1) ATE482706T1 (pt)
AU (1) AU2004210399B2 (pt)
BR (1) BRPI0407368A (pt)
CA (1) CA2515262C (pt)
CY (1) CY1110998T1 (pt)
DE (1) DE502004011696D1 (pt)
DK (1) DK1594500T3 (pt)
EC (1) ECSP055959A (pt)
HK (1) HK1089380A1 (pt)
HR (1) HRP20050786B1 (pt)
IL (1) IL170027A (pt)
MA (1) MA27632A1 (pt)
MX (1) MXPA05008407A (pt)
MY (1) MY144714A (pt)
NO (1) NO331524B1 (pt)
NZ (1) NZ541681A (pt)
PE (1) PE20050189A1 (pt)
PT (1) PT1594500E (pt)
RU (1) RU2373937C9 (pt)
SI (1) SI1594500T1 (pt)
TW (1) TWI347843B (pt)
UY (1) UY28179A1 (pt)
WO (1) WO2004069253A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7157455B2 (en) * 2003-02-10 2007-01-02 Hoffmann-La Roche Inc. 4-Aminopyrimidine-5-one derivatives
AU2004210399B2 (en) * 2003-02-10 2010-02-18 Bayer Intellectual Property Gmbh Treatment of bacterial diseases of the respiratory organs by locally applying fluoroquinolones
WO2006033713A2 (en) * 2004-08-09 2006-03-30 Chiron Corporation Methods for ciprofloxacin inhalation
CN101090711A (zh) 2004-10-29 2007-12-19 哈佛学院校长同事会 治疗肺部感染的颗粒
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
CA2900093C (en) * 2005-05-18 2018-11-13 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
MX2010012452A (es) * 2008-05-15 2011-03-15 Novartis Ag Star Suministro pulmonar de una fluoro-quinolona.
WO2010042549A1 (en) 2008-10-07 2010-04-15 Mpex Pharmaceuticals, Inc. Inhalation of levofloxacin for reducing lung inflammation
NZ592717A (en) 2008-10-07 2013-03-28 Mpex Pharmaceuticals Inc Aerosol fluoroquinolone formulations for improved pharmacokinetics comprising levofloxacin or ofloxacin and a di- or trivalent cation
WO2010048341A1 (en) 2008-10-22 2010-04-29 Inspire Pharmaceuticals, Inc. Method for treating cystic fibrosis
ES2739979T3 (es) 2009-09-04 2020-02-05 Horizon Orphan Llc Uso de levofloxacino en aerosol para el tratamiento de la fibrosis quística
US9393243B1 (en) 2015-07-14 2016-07-19 Nilesh Parikh Topical Ciprofloxacin compositions
WO2018074880A2 (ko) * 2016-10-20 2018-04-26 한국화학연구원 퀴놀린 4-온 유도체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 폐렴의 예방 또는 치료용 약학적 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
DE3033157A1 (de) 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3525335A1 (de) * 1985-07-16 1987-01-22 Bayer Ag Embonate von chinoloncarbonsaeuren und ihren derivaten
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
FR2655545B1 (fr) * 1989-12-11 1994-06-10 Rhone Poulenc Sante Nouvelle application therapeutique des derives des fluoroquinolones.
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
DE19633480A1 (de) * 1996-08-20 1998-02-26 Bayer Ag Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
DE19812160C1 (de) * 1998-03-20 1999-07-08 Bayer Ag Formkörper aus wirkstoffhaltigen thermoplastischen Polyurethanen
AU5528299A (en) * 1998-09-15 2000-04-03 Naeja Pharmaceutical Inc. Combined therapy for treatment of inflammation using elastase inhibitor(s) and antibacterial agent(s)
MXPA02004193A (es) * 1999-10-29 2002-12-13 Inhale Therapeutic Syst Composiciones de polvo seco que tienen caracteristicas de dispersion mejoradas.
DE19962470A1 (de) 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
WO2003075889A1 (en) * 2002-03-05 2003-09-18 Transave, Inc. An inhalation system for prevention and treatment of intracellular infections
EP1501483A2 (en) * 2002-04-25 2005-02-02 Nektar Therapeutics UK Ltd Particulate materials
AU2004210399B2 (en) * 2003-02-10 2010-02-18 Bayer Intellectual Property Gmbh Treatment of bacterial diseases of the respiratory organs by locally applying fluoroquinolones

Also Published As

Publication number Publication date
CA2515262A1 (en) 2004-08-19
DE502004011696D1 (de) 2010-11-11
PT1594500E (pt) 2010-12-17
CY1110998T1 (el) 2015-06-11
TWI347843B (en) 2011-09-01
NO20054180L (no) 2005-09-08
HK1089380A1 (en) 2006-12-01
UY28179A1 (es) 2004-09-30
US8034817B2 (en) 2011-10-11
NO20054180D0 (no) 2005-09-08
AU2004210399B2 (en) 2010-02-18
DK1594500T3 (da) 2011-01-24
PE20050189A1 (es) 2005-05-22
KR101173696B1 (ko) 2012-08-13
MY144714A (en) 2011-10-31
CA2515262C (en) 2013-09-03
JP2006517210A (ja) 2006-07-20
US20120010215A1 (en) 2012-01-12
MXPA05008407A (es) 2005-10-05
NZ541681A (en) 2009-02-28
AR043117A1 (es) 2005-07-20
RU2373937C9 (ru) 2010-07-27
KR20050098309A (ko) 2005-10-11
ATE482706T1 (de) 2010-10-15
JP4828405B2 (ja) 2011-11-30
EP1594500B1 (de) 2010-09-29
JP2011173929A (ja) 2011-09-08
HRP20050786A2 (en) 2006-10-31
AU2004210399A1 (en) 2004-08-19
SI1594500T1 (sl) 2011-02-28
EP1594500A1 (de) 2005-11-16
RU2373937C2 (ru) 2009-11-27
IL170027A (en) 2012-02-29
MA27632A1 (fr) 2005-11-01
TW200503716A (en) 2005-02-01
ECSP055959A (es) 2006-01-16
US20040254194A1 (en) 2004-12-16
RU2005128132A (ru) 2006-02-10
WO2004069253A1 (de) 2004-08-19
NO331524B1 (no) 2012-01-23
HRP20050786B1 (hr) 2015-01-02

Similar Documents

Publication Publication Date Title
ECSP055959A (es) Tratamiento de enfermedades bacterianas de los organos respiratorios
BR0312729A (pt) Novos derivados de indol-3-enxofre
ATE381535T1 (de) Phenethanolaminderivate
CY1115940T1 (el) Παραγωγα υποκατεστημενου φαινυλαλκανοϊκου οξεος και η χρηση τους για τη θεραπευτικη αντιμετωπιση αναπνευστικων ασθενειων
BR0311126A (pt) Composições e método para tratar infecção em gado bovino e em suìnos
BRPI0413490A (pt) novos compostos
EA200700202A1 (ru) Гетероарильные соединения в качестве бетамиметиков для лечения заболеваний дыхательных путей
BRPI0414425A (pt) composições farmacêuticas
NO20071577L (no) Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
NO20064186L (no) Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod
BRPI0515483A (pt) derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase
BRPI0410795A (pt) composições para tratamento de infecção em bovinos e suìnos
EA201000609A1 (ru) Замещенные пиперидинодигидротиенопиримидины
BR0214962A (pt) Composição para tratar distúrbios neurocerebrovasculares
EA200401114A2 (ru) Замещённые гидроксиэтиламины
NO20076405L (no) Anvendelse av 24-nor-UDCA
BR0312696A (pt) Tratamento tópico de doenças da pele
BRPI0419273A (pt) composições e métodos para tratar infecções microbianas e parasìticas em gado vacum e outros animais
BRPI0513647A (pt) derivados de ácidos 1-fenilalcanocarboxìlicos para o tratamento de doenças neurodegenerativas
NZ597657A (en) Use sulphur particles less than 300 microns and sodium lignin sulfonate for treating diseases casused by microbial pathogenic infections
ATE505193T1 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
UA84696C2 (ru) Лечение бактериальных заболеваний органов дыхания путем местного применения фторхинолонов
DOP2004000816A (es) Tratamiento de enfermedades bacterianas de los organos respiratorios
ATE374608T1 (de) Verwendung von silibinin mit alpha-liponsäure zur behandlung chronisch obstruktiver lungenerkrankungen

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BAYER SCHERING PHARMA AKTIENDESELLSCHAFT (DE)

Free format text: TRANSFERIDO POR FUSAO DE: BAYER HEALTHCARE AG

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25D Requested change of name of applicant approved

Owner name: BAYER PHARMA AKTIENGESELLSCHAFT (DE)

B25A Requested transfer of rights approved

Owner name: BAYER INTELLECTUAL PROPERTY GMBH. (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]